
Citation: Oluwafolajimi Adetoye Adesanya, Hilda Amauche Igwe. Carbapenem-resistant Enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance study[J]. AIMS Public Health, 2020, 7(4): 804-815. doi: 10.3934/publichealth.2020062
[1] | Ilenia Piras, Vanessa Usai, Paolo Contu, Maura Galletta . Vicarious trauma, coping strategies and nurses' health outcomes: An exploratory study. AIMS Public Health, 2024, 11(4): 1071-1081. doi: 10.3934/publichealth.2024055 |
[2] | Thiresia Sikioti, Afroditi Zartaloudi, Despoina Pappa, Polyxeni Mangoulia, Evangelos C. Fradelos, Freideriki Eleni Kourti, Ioannis Koutelekos, Evangelos Dousis, Nikoletta Margari, Areti Stavropoulou, Eleni Evangelou, Chrysoula Dafogianni . Stress and burnout among Greek critical care nurses during the COVID-19 pandemic. AIMS Public Health, 2023, 10(4): 755-774. doi: 10.3934/publichealth.2023051 |
[3] | Val Bellman, David Thai, Anisha Chinthalapally, Nina Russell, Shazia Saleem . Inpatient violence in a psychiatric hospital in the middle of the pandemic: clinical and community health aspects. AIMS Public Health, 2022, 9(2): 342-356. doi: 10.3934/publichealth.2022024 |
[4] | Yosef Mohamed-Azzam Zakout, Fayez Saud Alreshidi, Ruba Mustafa Elsaid, Hussain Gadelkarim Ahmed . The magnitude of COVID-19 related stress, anxiety and depression associated with intense mass media coverage in Saudi Arabia. AIMS Public Health, 2020, 7(3): 664-678. doi: 10.3934/publichealth.2020052 |
[5] | Abdulqadir J. Nashwan, Rejo G. Mathew, Reni Anil, Nabeel F. Allobaney, Sindhumole Krishnan Nair, Ahmed S. Mohamed, Ahmad A. Abujaber, Abbas Balouchi, Evangelos C. Fradelos . The safety, health, and well-being of healthcare workers during COVID-19: A scoping review. AIMS Public Health, 2023, 10(3): 593-609. doi: 10.3934/publichealth.2023042 |
[6] | Liam Ishaky, Myuri Sivanthan, Behdin Nowrouzi-Kia, Andrew Papadopoulos, Basem Gohar . The mental health of laboratory and rehabilitation specialists during COVID-19: A rapid review. AIMS Public Health, 2023, 10(1): 63-77. doi: 10.3934/publichealth.2023006 |
[7] | Bahar Kefeli Çol, Ayşe Gümüşler Başaran, Hilal Pekmezci . COVID-19 pandemic: Evaluating its psychological impact and individuals' depression, anxiety, and stress levels. AIMS Public Health, 2023, 10(3): 507-523. doi: 10.3934/publichealth.2023036 |
[8] | Margarida A. R. Tomás, Marisa R. Soares, Joaquim M. Oliveira-Lopes, Luís M. M. Sousa, Vânia L. D. Martins . The influence of nursing handover on nurses' mental health: A scoping review. AIMS Public Health, 2025, 12(1): 106-123. doi: 10.3934/publichealth.2025008 |
[9] | Ilenia Piras, Igor Portoghese, Massimo Tusconi, Federica Minafra, Mariangela Lecca, Giampaolo Piras, Paolo Contu, Maura Galletta . Professional and personal experiences of workplace violence among Italian mental health nurses: A qualitative study. AIMS Public Health, 2024, 11(4): 1137-1156. doi: 10.3934/publichealth.2024059 |
[10] | Maryanna Klatt, Jacqueline Caputo, Julia Tripodo, Nimisha Panabakam, Slate Bretz, Yulia Mulugeta, Beth Steinberg . A highly effective mindfulness intervention for burnout prevention and resiliency building in nurses. AIMS Public Health, 2025, 12(1): 91-105. doi: 10.3934/publichealth.2025007 |
Late December 2019, The COVID-19 pandemic (coronavirus) began in Wuhan, China, and quickly spread around the world. Its novelty signifies that there is no existing community (herd) immunity and/or vaccine, which has required the great majority of the world's states to adopt strict measures such as lockdown or partial confinement. The impact of confinement measures on economic activity may become immense. Some sectors are totally paralysed: tourism, catering, while many employees could find themselves in short-time work [1].
Algeria reported the first case of COVID-19 on 25 February 2020 [2],[3]. Since then, it has progressed rapidly and the number of cases tested positive grows exponentially each day. Figure 1 represents the cumulative number of detected cases of coronavirus in Algeria between March 01 and September 11, 2020 [2]. The cumulative number of COVID-19 cases is classified in three phases: The first phase (or phase A) corresponding to pre-intervention (e.g. from March 01 to April 10, 2020), the second phase (phase B) (between April 11 and June 13, 2020) corresponding to the intervention period when drastic measures were suddenly taken to slow the spread of the epidemic (closure of schools, restaurants, confinement, etc.). The third and final phase (phase C) (beginning from June 14, 2020), after curbing the epidemic, Algeria sees a rebound in COVID-19 cases. This came a few days after the government's decision to relax the measures adopted, particularly with the progressive reopening of stores, the resumption of public transport and other public places.
It may be difficult now to plan again strict confinement measures to slow spread of COVID-19 because it will affect the country's economy as all industries and import exports will cease. To deal with this situation, the population can undertake various non-pharmaceutical measures such as physical distancing and wearing masks [4]–[6].
Multiple epidemiological models have been proposed to predict the spread of COVID-19 epidemic and to evaluate the effectiveness of control measures to reduce and stop the virus spread, see for example [7]–[10]. In [11], the authors present a network model for the spread of COVID-19 pandemic based on the classical SIR model, random graph and percolation theory concepts to describe the impact of lockdown measures within a population.
The goal of this work is to propose a simple model allowing to examine the efficacy of near population-wide adoption of masks and physical distancing to bring down the basic reproduction number ℜ0, by reducing the number of people that are involved in physical interaction. ℜ0 is a conceptual parameter which provides some information about the expected speed through which a disease can propagate into a population. The organization of this paper is as follows. In the next section we present the SIR model without intervention and connecting its parameters to reported case data, we also derive the basic reproduction number and sharp estimates for the final size relation. In section 3, we present data in a way to get insight into the trend of the spread of COVID-19 during different phases of confinement in Algeria, we calculate the average rise of confirmed cases in each phase. In section 4, we examine the effects of physical distance and face masks on virus transmission by numerical simulation. We conclude the paper by section 5, where some detailed conclusions and discussions are presented.
To model the dynamic of the disease and predict the number of COVID-19 cases in Algeria, we use a standard SIR model described by Kermack and McKendrick [12]. The population is divided into three groups: susceptible, S, who can contract the disease, the infectives, I, those who have the disease and may transmit it, and the removed class, R where individuals out of the infection chain are put: isolated people, deceased and cured. The SIR model can be written as follows:
where β is the transmission rate per infectious individual and
We now illustrate the predictions of the SIR model without intervention (1)–(3). The model is parameterized using the number of cases tested positive until 10 April (that is before intervention). We utilize the least squares method to estimate the parameters, which is implemented by the fminsearch command, found in the optimization toolbox in MATLAB. The aim is then to minimize the sum of the squared residual errors:
where Rt is the cumulative number of reported COVID-19 and R(t,θ) is the theoretical confirmed cases calculated by the model on day t, n is the number of reported data. The set of parameter vectors θ constrained by a prespecified feasible region, here denoted by Θ.
The minimization leads to an estimate of θ = (β,γ). Based on the observed data the model parameters are estimated to β = 0.2044 and γ = 0.0971, thus ℜ0 = 2.1. The results are presented in Figure 2, we observe a good match with the data.
Let us return to the model (1)–(3). Let's determine what the final size of the epidemic will be in the absence of a complete intervention.
First of all, it is not difficult to prove that (see for example [15])
Equation (1) shows that
Integrating between t=0 and t = ∞, we get:
Equation (2) can be rewritten as
Integrating between t=0 and t = ∞, we get:
Combining the two results (4), (6), and using the fact that
If the entire population is initially susceptible, i.e., S(0) = N − 1 and I(0) = 1, the equation (7) can be written as
We find numerically
Like almost every country in the world, from March 23rd, but more rigorously from April 10th, Algeria has adopted drastic measures to limit the spread of the virus throughout our territory. On the basis of our observation, the pandemic management strategy in Algeria can be divided into three phases:
● Phase A: (from March 01 to April 10, 2020) corresponding to pre-confinement measures where some instructions are imposed as the prohibition of sporting, cultural and political gatherings, football matches were taking place without an audience.
● Phase B: (from April 11 to June 13, 2020) corresponding to lockdown of some cities and partial confinement of the others. This strategy has reduced contact and has surely reduced the spread of COVID-19 among the population, meaning gains for public health, while they reduced presence at the work-place, in restaurants, shops and other places of economic activity, involving economic costs, etc.
● Phase C: began from June 14 and corresponding to release from confinement, which is both progressive and flexible and in which they have decided the priority of activities according to their socio-economic impact and the risk of transmission of COVID-19.
Figure 4 gives the number of average newly reported cases in each phase. At the beginning of the epidemic, Algeria was not doing enough testing because there were few test kits available, making it difficult to assess the scale of the coronavirus epidemic in the country, which justifies the relatively slow spread of phase A. The actual number of infected patients in phase A must be higher as reported.
A few days after the outbreak began, the government has imported testing kits. In addition, the 20 laboratories spread across the country carry out over 2,500 COVID-19 tests per day on average against about 200/day at the beginning of the epidemic which justifies the significant increase in the number of daily cases of the new coronavirus in phase B. There is a rapid increase in confirmed COVID-19 patients in phase C as an effect of relaxation in confinement. We registered an average of around 43 new cases daily during phase A, 141 in phase B while 408 in phase C. On July 24, Algeria recorded 675 cases of coronavirus infections. This is the highest number ever since the first confirmed case in Algeria as shown in Figure 5. However, this number should be correlated with the increase in screening tests.
The strict confinement measures taken in Phase B showed a slow and reasonably controlled spread of COVID-19, as intended. It was effectively achieving its goal of controlling the pandemic in the country, but on the other hand, it was causing some difficulties for daily betting and small businesses. Algeria, like several other countries, began process of release from confinement in order to minimize the economic damage caused by this health crisis.
A few days after relaxation of confinement, the number of new daily cases increased suddenly. If this situation is not well-handled, it could become uncontrollable, and it will be difficult for our hospitals to treat a large number of patients with coronavirus at the same time.
With the impossibility to return to strict confinement which could have even worse effects on the economy, face masks and physical distancing can reduce coronavirus transmission in communities where there are asymptomatic individuals or people with mild symptoms who are not diagnosed and continue to interact with other people.
In this section, we aim to investigate the effectiveness of physical distancing and face masks on the propagation of the virus. Let us assume that at the time of unconfinement, a proportion of the population “m” wears masks with some degree of protection e and a proportion “d” of the population practicing physical distancing without wearing masks. Based on our work [4], the SIR model with using mask and respecting social distancing is given by the system:
The effective reproduction number at the time of released from confinement is
and so long as the number of disease cases is small compared to the population size, this is approximately
One can easily confirm that in the simple case of free behavior, that this to say no mask (m=0) and without social distancing (d=0), ℜe = ℜ0. Similarly, in the case of 100% mask adoption level, (m=1) with guaranteed effectiveness (e=1), or when all individuals practice physical distancing (d=1), then ℜe = 0.
We now examine the tradeoff between the portion of population wearing masks with certain filter efficiency e and the rest of this population who practicing only physical distancing for which ℜe becomes equal to unity.
Equation (13) can be interpreted as a balance equation, saying that how the portion of population wearing masks depends on mask efficiency and on the fraction of population practicing physical distancing. To make some headway it may be useful to resort to a numerical representation of the situation arising from (13).
Figure 6 is a graphical representation of the critical fraction of the population respecting physical distance d versus the fraction of the population wearing masks m for various values of ℜ0 and e. As an example, assume that the mask efficiency is 0.5, and at least 30% of the population who don't wear masks engaging in physical distancing. In the case when ℜ0 = 3, Figure 6 shows that it is possible to lift totally confinement with success with masks worn by about 36% of the population. Whereas for ℜ0 = 2.5, we need on average 20% of the population wearing these masks. For ℜ0 = 1.5, we don't need to wear face masks to slow the spread of Covid-19 if 30% of the population practice social distancing. Figure 6 shows also that the higher the levels of mask efficiency, the more the level curve corresponding to ℜe = 1 is shifted at the bottom-left of each of the sub-figures, which means that there is a very close relationship between the portion wearing masks and the efficiency of these masks. As an example, for ℜ0 = 3, assume that 30% of the population practice physical distancing, then for a mask critical efficiency of 0.5, the mask adoption level is at least 36%. If the mask efficiency was 0.7, the mask adoption rate is reduced to about 25%. This rate is well below 18% if the mask efficiency was 1.
In Figure 7, we find the threshold of population wearing masks with some efficiency for which ℜe becomes equal to unity when a portion of the population engages in distancing measures. Figure 7 is a plot of the critical mask efficiency e versus the mask adoption level m for various values of ℜ0 and d. For ℜ0 = 3, if for example, 50% of the population that engages in physical distancing, then the effective reproduction number decreases with 75% of its original value according to this simplified model. Hence, the epidemic can be stopped without need face masks. Whereas when physical distancing can't be observed (d=0), it is needed to use masks worn by a portion m = 72% of the population and with efficacy almost equal to 60%. If 30% of the population respecting physical distancing and assume that the mask adoption level is 40%, then for ℜ0 = 3, Figure 7 indicates a mask critical efficiency of 50%. For ℜ0 = 2.5, the mask critical efficiency is reduced to about 30%. Whereas for ℜ0 = 1.5, the epidemic can be stopped without need face masks.
For a fixed d, Figure 7 shows that the higher the ℜ0, the more the level curve corresponding to ℜe is shifted at the top right of each of the sub-figures, which means that to avoid a second peak after unconfinement, it is necessary to ask a larger portion of the population to wear increasingly effective masks. Our model also indicates that if the half of the population respects physical distancing, it is not necessary to wear masks, unfortunately, this is not respected especially in closed places, which allows to encourage the general public to wear masks.
Equations were derived that give critical levels of portion of the population practicing physical distancing, mask adoption and mask efficiency that lower the effective reproduction number ℜe of a SIR-based epidemiological model to unity. These critical levels correspond to a strong reduction, towards zero, of the final number of cumulative infections. It would be much more effective for the population to adopt masks that exceed the critical mask efficiencies derived herein, and the people who don't wear masks must maintain physical distance.
To estimate the effective reproduction number, based on our simplified model, we thus needed an estimate of the following two parameters:
1. The portion of the population that engages in physical distancing.
2. The portion of the population that wear masks.
So, if face mask usage and physical distancing were to become a common behaviour, one can expect the number of diseases and deaths from COVID-19 to be reduced, especially if population compliance is high until such time as a pandemic vaccine becomes available.
Our research indicates also that public mask wearing is likely beneficial as source control when worn by persons shedding infectious coronavirus when physical distancing is not possible in public spaces. Finally in the last section we discuss the biological significance of our results.
Note that the model used here is highly simplified, it assume that the population has homogeneous mixing, with a fixed product of the number of contacts per day and of the probability of infection per contact. However, in some situations, for example at home, one would not normally expect people to wear masks, such limitations also apply to physical distancing. In the future, we plan to develop mathematical models taking into account the daily movements of individuals in different places, home, schools and universities, workplaces, transport and public places, shops where the risks of infection are different.
[1] | (2014) World Health Organisation (WHO)Antimicrobial Resistance: Global Report on Surveillance. Geneva: . Available from: https://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf;jsessionid=DF1DFD88C7B094F3DD20B313C898B4D5?sequence=1 |
[2] |
Tamma PD, Goodman KE, Harris AD, et al. (2017) Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia. Clin Infect Dis 64: 257-264. doi: 10.1093/cid/ciw741
![]() |
[3] |
Queenan AM, Bush K (2007) Carbapenemases: The versatile β-lactamases. Clin Microbiol Rev 20: 440-458. doi: 10.1128/CMR.00001-07
![]() |
[4] |
Ruppé É, Woerther PL, Barbier F (2015) Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care 5: 21. doi: 10.1186/s13613-015-0061-0
![]() |
[5] | Giakoupi P, Maltezou H, Polemis M, et al. (2009) KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 14. |
[6] |
Woodford N, Tierno PM, Young K, et al. (2004) Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 48: 4793-4799. doi: 10.1128/AAC.48.12.4793-4799.2004
![]() |
[7] |
Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infec Dis 9: 228-236. doi: 10.1016/S1473-3099(09)70054-4
![]() |
[8] |
Woodford N, Turton JF, Livermore DM (2011) Multiresistant Gram-negative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance. Fems Microbiol Rev 35: 736-755. doi: 10.1111/j.1574-6976.2011.00268.x
![]() |
[9] |
Cantón R, Akóva M, Carmeli Y, et al. (2012) Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18: 413-431. doi: 10.1111/j.1469-0691.2012.03821.x
![]() |
[10] |
Gupta N, Limbago BM, Patel JB, et al. (2011) Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention. Clin Infect Dis 53: 60-67. doi: 10.1093/cid/cir202
![]() |
[11] |
Nordmann P, Naas T, Poirel L (2011) Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis 17: 1791-1798. doi: 10.3201/eid1710.110655
![]() |
[12] | Zhang YW, Wang Q, Yin YY, et al. (2018) Epidemiology of Carbapenem-Resistant Infections: Report from the China CRE Network. Antimicrob Agents Chemother 62: e01882. |
[13] |
Freeman R, Moore LSP, García Álvarez L, et al. (2013) Advances in electronic surveillance for healthcare-associated infections in the 21st Century: A systematic review. J Hosp Infect 84: 106-119. doi: 10.1016/j.jhin.2012.11.031
![]() |
[14] | The University College Hospital. Available from: https://www.uch-ibadan.org.ng. |
[15] |
Chester B, Moskowitz L (1987) Rapid Catalase Supplemental Test for Identification of Members of the Family Enterobacteriaceae. J Clin Microbiol 25: 439-441. doi: 10.1128/JCM.25.2.439-441.1987
![]() |
[16] | Clinical and Laboratory Standards Institute (2015) M02-A12 Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard-Twelfth Edition. Available from: https://clsi.org/media/1631/m02a12_sample.pdf. |
[17] |
Morrill HJ, Pogue JM, Kaye KS, et al. (2015) Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. Open Forum Infect Dis 2: 1-15. doi: 10.1093/ofid/ofv130.01
![]() |
[18] |
Ampaire L, Katawera V, Nyehangane D, et al. (2015) Epidemiology of Carbapenem Resistance among Multi-drug Resistant Enterobacteriaceae in Uganda. Br Microbiol Res J 8: 418-423. doi: 10.9734/BMRJ/2015/17055
![]() |
[19] |
Mushi MF, Mshana SE, Imirzalioglu C, et al. (2014) Carbapenemase Genes among Multidrug Resistant Gram Negative Clinical Isolates from a Tertiary Hospital in Mwanza, Tanzania. Biomed Res Int 2014: 6. doi: 10.1155/2014/303104
![]() |
[20] |
Mohanty S, Gajanand M, Gaind R (2017) Identification of carbapenemase-mediated resistance among Enterobacteriaceae bloodstream isolates: A molecular study from India. Indian J Med Microbiol 35: 421-425. doi: 10.4103/ijmm.IJMM_16_386
![]() |
[21] |
Messaoudi A, Mansour W, Jaidane N, et al. (2019) Epidemiology of resistance and phenotypic characterization of carbapenem resistance mechanisms in Klebsiella pneumoniae isolates at Sahloul University Hospital-Sousse, Tunisia. Afr Health Sci 19: 2008-2020. doi: 10.4314/ahs.v19i2.24
![]() |
[22] |
Shettima SA, Tickler IA, Dela Cruz CM, et al. (2019) Characterisation of carbapenem-resistant Gram-negative organisms from clinical specimens in Yola, Nigeria. J Glob Antimicrob Resist 21: 42-45. doi: 10.1016/j.jgar.2019.08.017
![]() |
[23] |
Ogbolu DO, Webber MA (2014) High-level and novel mechanisms of carbapenem resistance in Gram-negative bacteria from tertiary hospitals in Nigeria. Int J Antimicrob Agents 43: 412-417. doi: 10.1016/j.ijantimicag.2014.01.014
![]() |
[24] |
Olalekan A, Onwugamba F, Iwalokun B, et al. (2020) High proportion of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among extended-spectrum β-lactamase-producers in Nigerian hospitals. J Glob Antimicrob Resist 21: 8-12. doi: 10.1016/j.jgar.2019.09.007
![]() |
[25] | Freeman R, Moore LSP, Charlett A, et al. (2015) Exploring the epidemiology of carbapenem-resistant Gram-negative bacteria in west London and the utility of routinely collected hospital microbiology data. J Antimicrob Chemother 70: 1212-1218. |
[26] | Thomas TS, Duse AG (2018) Epidemiology of carbapenem-resistant Enterobacteriaceae (CRE) and comparison of the phenotypic versus genotypic screening tests for the detection of carbapenemases at a tertiary level, academic hospital in Johannesburg, South Africa. South African J Infect Dis 0: 1-7. |
[27] |
Van Duin D, Perez F, Rudin SD, et al. (2014) Surveillance of carbapenem-resistant Klebsiella pneumoniae: Tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother 58: 4035-4041. doi: 10.1128/AAC.02636-14
![]() |
[28] |
Patel N, Harrington S, Dihmess A, et al. (2011) Clinical epidemiology of carbapenem-intermediate or-resistant Enterobacteriaceae. J Antimicrob Chemother 66: 1600-1608. doi: 10.1093/jac/dkr156
![]() |
[29] |
Wang Q, Zhang Y, Yao X, et al. (2016) Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur J Clin Microbiol Infect Dis 35: 1679-1689. doi: 10.1007/s10096-016-2710-0
![]() |
[30] |
Onofrio VD, Conzemius R, Varda-brkić D, et al. (2020) Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia. Infect Genet Evol 81: 104263. doi: 10.1016/j.meegid.2020.104263
![]() |
[31] |
Hashemi MM, Rovig J, Weber S, et al. (2017) Susceptibility of colistin-resistant, gram-negative bacteria to antimicrobial peptides and ceragenins. Antimicrob Agents Chemother 61: e00292. doi: 10.1128/AAC.00292-17
![]() |
[32] |
Gordillo Altamirano FL, Barr JJ (2019) Phage therapy in the postantibiotic era. Clin Microbiol Rev 32: e00066-e00068. doi: 10.1128/CMR.00066-18
![]() |
1. | Yusuff Adebayo Adebisi, Adrian Rabe, Don Eliseo Lucero-Prisno III, Risk communication and community engagement strategies for COVID-19 in 13 African countries, 2021, 11, 2228-6497, 137, 10.34172/hpp.2021.18 | |
2. | Min Seo Kim, Dawon Seong, Han Li, Seo Kyoung Chung, Youngjoo Park, Minho Lee, Seung Won Lee, Dong Keon Yon, Jae Han Kim, Keum Hwa Lee, Marco Solmi, Elena Dragioti, Ai Koyanagi, Louis Jacob, Andreas Kronbichler, Kalthoum Tizaoui, Sarah Cargnin, Salvatore Terrazzino, Sung Hwi Hong, Ramy Abou Ghayda, Joaquim Radua, Hans Oh, Karel Kostev, Shuji Ogino, I‐Min Lee, Edward Giovannucci, Yvonne Barnett, Laurie Butler, Daragh McDermott, Petre‐Cristian Ilie, Jae Il Shin, Lee Smith, Comparative effectiveness of N95, surgical or medical, and non‐medical facemasks in protection against respiratory virus infection: A systematic review and network meta‐analysis, 2022, 32, 1052-9276, 10.1002/rmv.2336 | |
3. | Hector Eduardo Roman, Fabrizio Croccolo, Spreading of Infections on Network Models: Percolation Clusters and Random Trees, 2021, 9, 2227-7390, 3054, 10.3390/math9233054 | |
4. | Ayoub Bouissa, Mostafa Tahiri, Najib Tsouli, Moulay Rchid Sidi Ammi, Global dynamics of a time-fractional spatio-temporal SIR model with a generalized incidence rate, 2023, 69, 1598-5865, 4779, 10.1007/s12190-023-01932-1 | |
5. | Ahmed Hamimes, Mohamed Lounis, Hani Amir Aouissi, Rabih Roufayel, Abdelhak Lakehal, Hafid Bouzekri, Haewon Byeon, Mostefa Ababsa, Christian Napoli, The Role of Vaccination and Face Mask Wearing on COVID-19 Infection and Hospitalization: A Cross-Sectional Study of the MENA Region, 2023, 11, 2227-9032, 1257, 10.3390/healthcare11091257 | |
6. | Mohammed Meziane, Ali Moussaoui, Vitaly Volpert, On a two-strain epidemic model involving delay equations, 2023, 20, 1551-0018, 20683, 10.3934/mbe.2023915 | |
7. | Tri Nguyen-Huu, Pierre Auger, Ali Moussaoui, On Incidence-Dependent Management Strategies against an SEIRS Epidemic: Extinction of the Epidemic Using Allee Effect, 2023, 11, 2227-7390, 2822, 10.3390/math11132822 | |
8. | Ali Moussaoui, Mohammed Meziane, On the date of the epidemic peak, 2024, 21, 1551-0018, 2835, 10.3934/mbe.2024126 | |
9. | Caitriona Murphy, Wey Wen Lim, Cathal Mills, Jessica Y. Wong, Dongxuan Chen, Yanmy Xie, Mingwei Li, Susan Gould, Hualei Xin, Justin K. Cheung, Samir Bhatt, Benjamin J. Cowling, Christl A. Donnelly, Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings, 2023, 381, 1364-503X, 10.1098/rsta.2023.0132 | |
10. | Ali Moussaoui, Vitaly Volpert, The impact of immune cell interactions on virus quasi-species formation, 2024, 21, 1551-0018, 7530, 10.3934/mbe.2024331 |